9

General Information


DRACP ID  DRACP04814

Peptide Name   9

Sequence  YSX

Sequence Length  3

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Cα -dialkylated glycine (Aaa2,2 )

Chiral  L



Physicochemical Information


Formula  C12H14N2O4

Absent amino acids  ACDEFGHIKLMNPQRTVW

Common amino acids  SYX

Mass  39610

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  -354

Hydrophobicity  -70

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  745

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16722632

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  3872

CancerPPD ID  3873

CancerPPD ID  3874

CancerPPD ID  3875

CancerPPD ID  3876

CancerPPD ID  3877

CancerPPD ID  3878

CancerPPD ID  3879

CancerPPD ID  3880

CancerPPD ID  3881

CancerPPD ID  3882

CancerPPD ID  3883

CancerPPD ID  3884

CancerPPD ID  3885

CancerPPD ID  3886

CancerPPD ID  3887

CancerPPD ID  3888

CancerPPD ID  3889

CancerPPD ID  3890

CancerPPD ID  3891

CancerPPD ID  3892

CancerPPD ID  3893

CancerPPD ID  3894

CancerPPD ID  3895

CancerPPD ID  3896

CancerPPD ID  3897

CancerPPD ID  3898

CancerPPD ID  3899

CancerPPD ID  3900

DRACP is developed by Dr.Zheng's team.